Jupiter Orphan Therapeutics takes in $2 mln
Florida-based Jupiter Orphan Therapeutics Inc, which is developing therapies for rare diseases linked to single gene deficiencies, has secured $2 million in financing. The investor is Tarnagulla Ventures.
5 January 2017•1 min read
